Tricida Inc. (TCDA) Fundamentals

Tricida Inc is a pharmaceutical company focused on the development and commercialization of its drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis by binding and removing acid from the gastrointestinal, or GI, tract. The primary area of focus is to slow the progression of chronic kidney disease through the treatment of metabolic acidosis.
SHARE INFORMATION
Market CapUS$ 12.696.582
Shares Outstanding58.028.254
Float33.592.901
Percent Float57,89%
Short Interest0,00
Short Percent Float0,0%
Short Interest Ratio0,00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0,00
Latest Fiscal RevenueUS$ 0
Latest Fiscal EPSUS$ -3,44
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)US$ 0,00
Dividend (5 Years)US$ 0,00
Ex Dividend Date-
Dividend RateUS$ 0,00
Dividend Yield0,0%
Payment Cash-
HOLDERS
Institutions263
Institutional Holdings Date2022-11-30
Institutional Bought Previous 3 Months6.040.808
Institutional Holdings Percent93,3%
Institutional Sold Previous 3 Months6.661.130
Insider Holdings Date2022-11-30
Insider Bought Previous 3 Months2.644.995
Insider Holdings Percent1,7
Insider Sold Previous 3 Months7.139.965
Insider Shares Owned987.447
TRADING INFO
52 Week HighUS$ 13,85
52 Week LowUS$ 0,19
52 Week High ChangeUS$ -97,17
21 Day Moving AverageUS$ 0,245
21 Day Extended Moving AverageUS$ 0,827384
50 Day Moving AverageUS$ 4,4856
50 Day Extended Moving AverageUS$ 3,4218
200 Day Moving AverageUS$ 8,5384
200 Day Extended Moving AverageUS$ 7,3755
10 Day Average Volume18.168.991
20 Day Average Volume14.450.823
30 Day Average Volume17.498.251
50 Day Average Volume12.881.346
Alpha-0.020712
Beta0.0761
Standard Deviation0.261169
R20.000263
7 Day Price ChangeUS$ -0,0538
7 Day Percent Change-19,74%
21 Day Price ChangeUS$ -0,0255
21 Day Percent Change-10,44%
30 Day Price ChangeUS$ -0,0618
30 Day Percent Change-22,02%
Month to Date Price ChangeUS$ -0,0212
Month to Date Percent Change-8,83%
Quarter to Date Price ChangeUS$ -10,26
Quarter to Date Percent Change-97,91%
180 Day Price ChangeUS$ -9,17
180 Day Percent Change-97,67%
200 Day Price ChangeUS$ -9,37
200 Day Percent Change-97,72%
Year to Date Price ChangeUS$ -9,34
Year to Date Percent Change-97,71%

Tricida Inc. (TCDA) Key Ratios

PROFITABILITY
EBIT Margin0,0%
EBITDA Margin0,0%
Pre-Tax Profit Margin0,0%
Profit Margin Count0,0%
Gross Margin0,0%
Profit Margin TOT0,0%
INCOME STATEMENTS
RevenueUS$ 0
Revenue Per ShareUS$ 0,00
Revenue (3 Years)US$ 0,00
Revenue (5 Years)US$ 0,00
FINANCIAL STRENGTH
Price to Tangible Book-0,10
Total Debt To Equity649,30
Int Coverage-12,40
Current Ratio4,90
Leverage Ratio-1,50
Quick Ratio4,70
Long Term Debt To Capital1,00
VALUATION MEASURES
PE Ratio-0,10
Enterprise ValueUS$ 140.994.836
Price to Sales0,00
Price to Free Cash-0,10
PE High Last 5 Years0,00
Price To Book2.323,80
Price To Cash Flow0,00
PE Low Last 5 Years0,00
Price to Tangible Book-0,10
MANAGEMENT EFFECTIVENESS
Receivables Turnover0,00
Invoice Turnover0,00
Assets Turnover0,00
Return Assets-103,62
Return on Equity199,58
Return on Capital-68,96

Tricida Inc. (TCDA) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorErnst & Young LLP
CEOGerrit Klaerner
Emplyoees57
Last AuditUQ
CIK0001595585
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address7000 Shoreline Court
Suite 201
South San Francisco, CA 94080
Websitehttps://www.tricida.com
Facsimile-
Telephone+1 415 429-7800
EmailIR@Tricida.com
Seu Histórico Recente
NASDAQ
TCDA
Tricida
Registre-se agora para acompanhar essas ações ao vivo no Monitor ADVFN.

O Monitor permite ver até 110 de suas ações favoritas de uma vez só e é completamente grátis para você usar.

Faça o login em ADVFN
Registrar agora
Cotações da NYSE e AMEX têm defasagem de no mínimo 20 minutos.
Quaisquer outras cotações têm defasagem de no mínimo 15 minutos quando não especificado.
Em caso de dúvidas por favor entre em contato com o suporte: suporte@advfn.com.br ou (11) 4950 5808.

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

P: V:br D:20221207 19:18:18